Page last updated: 2024-08-24

3-iodobenzylguanidine and Hypercalcemia

3-iodobenzylguanidine has been researched along with Hypercalcemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Galbavy, S; Kokavec, M; Svec, A; Zamborsky, R	1
Cross, SF; Dalla Pozza, L; Munns, CF	1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Hypercalcemia

Article	Year
Bone metastases in neuroendocrine tumors. Bratislavske lekarske listy, 2017, Volume: 118, Issue:9 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Chromogranin A; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Neuroendocrine Tumors; Radiotherapy; Somatostatin; Spinal Cord Compression; Surgical Procedures, Operative	2017

Article

Year

Bone metastases in neuroendocrine tumors.

Bratislavske lekarske listy, 2017, Volume: 118, Issue:9

Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Chromogranin A; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Neuroendocrine Tumors; Radiotherapy; Somatostatin; Spinal Cord Compression; Surgical Procedures, Operative

2017

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Hypercalcemia

Article	Year
Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma. Pediatric blood & cancer, 2009, Volume: 53, Issue:4 Topics: 3-Iodobenzylguanidine; Child; Humans; Hypercalcemia; Isotretinoin; Male; Neoplasm Recurrence, Local; Neuroblastoma; Osteoblasts	2009